AXNX

Axonics, Inc. (AXNX) | Rumor.io

Axonics

AXNX

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about AXNX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% 0

Jul 26

Boston Scientific's market cap is around $65 billion with a share price of $43, and enterprise value is around $62-$65 billion after accounting for debt.
The company has acquired Axonics and Silk Road Medical in recent deals.
Enterprise value and market cap are key metrics for evaluating the company's size and value.

Generated by AI

Sentiment

Of the messages about AXNX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100%	100%	100% 0
Bearish	0%	0%	0%	0% 0

Jul 26

Axonics, Inc. is valued competitively with Boston Scientific, considering enterprise value and market capitalization.
The company's recent acquisitions, such as Axonics, have contributed to its net debt load.
After accounting for net debt, Axonics' enterprise value sits around $62-$65 billion.

Generated by AI

Topics

Of the messages about AXNX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	0%	0%	0%	0%
Announcements	100%	100%	100%	100%
Controversies	0%	0%	0%	0%
Earnings	0%	0%	0%	0%
Macro	0%	0%	0%	0%
Technical Analysis	0%	0%	0%	0%

Jan 9

Boston Scientific has proposed a $3.7 billion acquisition of Axonics, with regulatory conditions including filing the HSR within 15 business days post-DMA by January 30.
The parties will make necessary regulatory filings under foreign jurisdictions within 45 days post-DMA by February 22, and the proxy statement shall be filed within 20 business days post-DMA by February 6.
Axonics shares rose 20.48% to $69.36 after the acquisition announcement, with the deal expected to close in the 1st half of 2024, and Axonics stock up 11.46% in 2024 and 24.21% year-over-year.

Generated by AI

Community

Of the messages about AXNX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	41.94%
Newcomers	100%	100%	100%	58.06%

Regulars· Jan 8

Axonics, Inc. has agreed to be acquired by Boston Scientific for $71 per share, representing an equity value of approximately $3.7 billion.
The acquisition is expected to strengthen Boston Scientific's neurostim portfolio, and the deal is expected to close in the coming months.
Axonics' stock has surged 20% in the pre-market trading, as the company's preliminary Q4 2023 and fiscal year 2023 revenue report is expected to be strong.

Newcomers· Jul 26

New users are comparing Axonics' market value to that of Boston Scientific, noting a potential long position.
The discussion focuses on the company's market capitalization, with estimates ranging from $65 to $65 billion.
Users are accounting for Axonics' debt load from recent acquisitions in their calculations of enterprise value.

Generated by AI

Also Discussed

Investors talking about AXNX also mention

#	Name	Attention
1	HARP - Harpoon Therapeutics, Inc.	——
2	SWAV - ShockWave Medical, Inc.	——
3	PRVB - Provention Bio, Inc.	——
4	Guardant Health Inc.GH	0%-0.11
5	DexCom Inc.DXCM	0%0
6	AMAM - Ambrx Biopharma Inc.	——
7	LivaNova PLCLIVN	0%0
8	Cable One Inc.CABO	0%-0.01
9	KRTX - Karuna Therapeutics, Inc.	——
10	CuriosityStream Inc.CURI	0%0

Axonics, Inc.

Location

Social

What share of all stock conversation is about AXNX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% 0

Jul 26

Boston Scientific's market cap is around $65 billion with a share price of $43, and enterprise value is around $62-$65 billion after accounting for debt.
The company has acquired Axonics and Silk Road Medical in recent deals.
Enterprise value and market cap are key metrics for evaluating the company's size and value.

Generated by AI

Sentiment

Of the messages about AXNX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100%	100%	100% 0
Bearish	0%	0%	0%	0% 0

Jul 26

Axonics, Inc. is valued competitively with Boston Scientific, considering enterprise value and market capitalization.
The company's recent acquisitions, such as Axonics, have contributed to its net debt load.
After accounting for net debt, Axonics' enterprise value sits around $62-$65 billion.

Generated by AI

Topics

Of the messages about AXNX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	0%	0%	0%	0%
Announcements	100%	100%	100%	100%
Controversies	0%	0%	0%	0%
Earnings	0%	0%	0%	0%
Macro	0%	0%	0%	0%
Technical Analysis	0%	0%	0%	0%

Jan 9

Boston Scientific has proposed a $3.7 billion acquisition of Axonics, with regulatory conditions including filing the HSR within 15 business days post-DMA by January 30.
The parties will make necessary regulatory filings under foreign jurisdictions within 45 days post-DMA by February 22, and the proxy statement shall be filed within 20 business days post-DMA by February 6.
Axonics shares rose 20.48% to $69.36 after the acquisition announcement, with the deal expected to close in the 1st half of 2024, and Axonics stock up 11.46% in 2024 and 24.21% year-over-year.

Generated by AI

Community

Of the messages about AXNX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	41.94%
Newcomers	100%	100%	100%	58.06%

Regulars· Jan 8

Axonics, Inc. has agreed to be acquired by Boston Scientific for $71 per share, representing an equity value of approximately $3.7 billion.
The acquisition is expected to strengthen Boston Scientific's neurostim portfolio, and the deal is expected to close in the coming months.
Axonics' stock has surged 20% in the pre-market trading, as the company's preliminary Q4 2023 and fiscal year 2023 revenue report is expected to be strong.

Newcomers· Jul 26

New users are comparing Axonics' market value to that of Boston Scientific, noting a potential long position.
The discussion focuses on the company's market capitalization, with estimates ranging from $65 to $65 billion.
Users are accounting for Axonics' debt load from recent acquisitions in their calculations of enterprise value.

Generated by AI

Axonics

Social

Jul 26

Sentiment

Jul 26

Topics

Jan 9

Community

Regulars· Jan 8

Newcomers· Jul 26

Also Discussed

Axonics, Inc.

Company Information

Location

Also Discussed

Social

Jul 26

Sentiment

Jul 26

Topics

Jan 9

Community

Regulars· Jan 8

Newcomers· Jul 26